$137 Million is the total value of Ponoi II Management, LLC's 5 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CNST | New | Constellation Pharmaceuticals Inc. | $45,338,000 | – | 1,574,229 | +100.0% | 33.03% | – |
| NGM | New | NGM Biopharmaceuticals Inc | $39,357,000 | – | 1,298,908 | +100.0% | 28.68% | – |
| RVMD | New | Revolution Medicines Inc | $27,120,000 | – | 685,011 | +100.0% | 19.76% | – |
| NRIX | New | Nurix Therapeutics Inc | $22,565,000 | – | 686,274 | +100.0% | 16.44% | – |
| RAPT | New | RAPT Therapeutics Inc | $2,872,000 | – | 145,401 | +100.0% | 2.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NGM Biopharmaceuticals Inc | 8 | Q3 2022 | 45.2% |
| Revolution Medicines Inc | 8 | Q3 2022 | 38.8% |
| Nurix Therapeutics Inc | 8 | Q3 2022 | 24.9% |
| RAPT Therapeutics Inc | 8 | Q3 2022 | 9.7% |
| Constellation Pharmaceuticals Inc. | 3 | Q2 2021 | 43.1% |
View Ponoi II Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-08 |
| 4 | 2023-11-17 |
| 4 | 2023-02-01 |
| 4 | 2023-01-25 |
| 4 | 2023-01-23 |
| 4 | 2023-01-17 |
| 4 | 2023-01-12 |
| 4 | 2022-12-14 |
| 4 | 2022-11-23 |
| 13F-HR | 2022-11-14 |
View Ponoi II Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.